A non-profit veterans organization in Florida, the Grey Team’s mission is to help reduce and eliminate PTSD-related veteran suicides CHARLOTTE, N.C.–(BUSINESS WIRE)–Sleepme Inc., the parent company of sleep technology brand ChiliSleep, announced today that it will provide 50 OOLER and Cube Sleep Systems to local veterans within the community and the veterans organization, Grey Team. … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global AI-based Clinical Trials Solution Provider Market Size, Share & Trends Analysis Report by Therapeutic Application, by Clinical Trial Phase, by End-use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global AI-based clinical trials solution provider market size is expected to reach USD 7.8 billion by 2030 … [Read more…]
A tireless health advocate, she dedicated her professional life to promoting healthy habits among the Hispanic community in the United States and Latin America. BROOKLYN, N.Y.–(BUSINESS WIRE)–VIDA Y SALUD MEDIA GROUP, the health communication company founded by Dr. Aliza Lifshitz and Carl Kravetz, together with HITN, which has been operating the Vida y Salud brand … [Read more…]
Suffolk donates $1.5 million of design and construction services to project; new expanded facility and clinical space to allow national nonprofit to serve more U.S. military veterans and families in need BOSTON–(BUSINESS WIRE)–Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, was selected by Home Base to renovate … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Clinical Indication and End User” report has been added to ResearchAndMarkets.com’s offering. The North America immunodiagnostic market is expected to reach US$ 15,040.40 million in 2028 from US$ 9,188.19 million in 2021. The market is estimated to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Single-Use Bioreactors Market Research Report by Product Type, Cell Type, Molecule Type, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Single-Use Bioreactors Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial … [Read more…]
CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today its participation in two November conferences, the Challenges and Opportunities for Mesenchymal Stem Cells digital conference being held November 17-18, 2022 and A.G.P.’s Biotech Conference on November 30, 2022. Robert W. Mays, M.D., Ph.D., Executive Vice President … [Read more…]
– IPX203 could offer people living with Parkinson’s disease a longer duration of symptom control with less frequent dosing compared to IR CD/LD treatment – The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of June 30, 2023. BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced the U.S. Food and Drug … [Read more…]
NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference in London, United Kingdom on Tuesday, November 15, 2022, at 8:35 a.m. GMT … [Read more…]
Clinical activity observed in third dosing cohort and sustained clinical benefit in second cohort AUSTIN, Texas & SOUTH SAN FRANCISCO, Calif. & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer, today announced updated … [Read more…]
